BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jadallah KA, Kullab SM, Sanders DS. Constipation-predominant irritable bowel syndrome: A review of current and emerging drug therapies. World J Gastroenterol 2014; 20(27): 8898-8909 [PMID: 25083062 DOI: 10.3748/wjg.v20.i27.8898] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
Number Citing Articles
1 Vázquez-Frias R, Consuelo-Sánchez A, Acosta-Rodríguez-Bueno CP, Blanco-Montero A, Robles DC, Cohen V, Márquez D, Perez M 3rd. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. Paediatr Drugs 2023;25:115-26. [PMID: 36380186 DOI: 10.1007/s40272-022-00536-9] [Reference Citation Analysis]
2 Madia VN, Messore A, Saccoliti F, Tudino V, De Leo A, De Vita D, Bortolami M, Scipione L, Pindinello I, Costi R, Di Santo R. Tegaserod for the Treatment of Irritable Bowel Syndrome. Antiinflamm Antiallergy Agents Med Chem 2020;19:342-69. [PMID: 31518227 DOI: 10.2174/1871523018666190911121306] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
3 Ferreira AI, Garrido M, Castro-Poças F. Irritable Bowel Syndrome: News from an Old Disorder. GE Port J Gastroenterol 2020;27:255-68. [PMID: 32775547 DOI: 10.1159/000503757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
4 Tack J, Stanghellini V, Mearin F, Yiannakou Y, Layer P, Coffin B, Simren M, Mackinnon J, Wiseman G, Marciniak A; IBIS-C Study group. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterol 2019;19:69. [PMID: 31064345 DOI: 10.1186/s12876-019-0985-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
5 Khlevner J, Park Y, Margolis KG. Brain-Gut Axis: Clinical Implications. Gastroenterol Clin North Am 2018;47:727-39. [PMID: 30337029 DOI: 10.1016/j.gtc.2018.07.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
6 Chen DP, Dong QY. Value of lactulose combined with prucalopride in treatment of refractory constipation in elderly patients with subarachnoid hemorrhage. Shijie Huaren Xiaohua Zazhi 2018; 26(9): 581-586 [DOI: 10.11569/wcjd.v26.i9.581] [Reference Citation Analysis]
7 Baker DE. Formulary Drug Reviews: Plecanatide. Hosp Pharm 2017;52:400-5. [PMID: 29276262 DOI: 10.1177/0018578717717623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis. World J Gastroenterol 2017; 23(2): 336-344 [PMID: 28127207 DOI: 10.3748/wjg.v23.i2.336] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
9 Chang L, Chey WD, Drossman D, Losch-Beridon T, Wang M, Lichtlen P, Mareya S. Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2016;44:1114-22. [PMID: 27669680 DOI: 10.1111/apt.13807] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
10 Wang YF, Liu J, Li R. Curative effect of mosapride vs prucalopride in treatment of chronic constipation in elderly patients. Shijie Huaren Xiaohua Zazhi 2015; 23(36): 5889-5893 [DOI: 10.11569/wcjd.v23.i36.5889] [Reference Citation Analysis]
11 Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015;114:1638-1646. [PMID: 26382580 DOI: 10.1017/s0007114515003347] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
12 Furnari M, de Bortoli N, Martinucci I, Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L, Savarino E, Giannini EG, Savarino V. Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag 2015;11:691-703. [PMID: 26028974 DOI: 10.2147/TCRM.S54298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
13 Moloney RD, O'Mahony SM, Dinan TG, Cryan JF. Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry 2015;6:15. [PMID: 25762939 DOI: 10.3389/fpsyt.2015.00015] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 12.4] [Reference Citation Analysis]